APAC Bioinformatics Market - Industry Trends Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143117
- Pages: 225
-
Format:
Short Description:
Asia-Pacific Bioinformatics Market, By Type (Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform)) Biological data interpretation, specialized bioinformatics application (single cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression and others), Services), Sector (medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology and others), Application( Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services), Purchase mode (group purchase and individual purchase), Genomics (Genomics (DNA and RNA), Proteomics) End User (Research and academic institute, Clinical research organization, biotech and pharmaceutical companies, research laboratories, hospitals and Others.), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia Philippines, Rest of Asia Pacific) Industry Trends & Forecast To 2029.
Market Definition:
Bioinformatics, which is connected to genetics and genomics, uses computer technology to gather, store, analyze, and share biological data and information, such as DNA and amino acid sequences or annotations about those sequences. The three components of bioinformatics are building databases, creating statistics and algorithms, data analysis, and interpretation. Identification of genes and proteins, as well as their functions, evolutionary relationships, and conformation prediction, are the main goals.
For instance,
In 2021, Agilent unveiled Sure-Select Human All Exon V8, a novel exome design that offers thorough content and coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes
The drivers responsible for the growth of the Asia-Pacific bioinformatics market are increased prevalence of use of bioinformatics equipment, decrease in the cost of genetic sequencing per base, technological advancements in the bioinformatics devices, and wide product portfolio offered by major players. However, the rise in the cost of devices, risks observed while using the devices, difficulty in using bioinformatics devices, and cybersecurity concerns in bioinformatics is expected to restrain the market growth.
On the other hand, strategic initiatives by key players, a rise in healthcare expenditure, and an increase in research and development activities may act as an opportunity for the growth of the global bioinformatics market. However, the need for skilled expertise and regulatory approval may create challenges for the global bioinformatics market.
Market Segmentation:
The Asia-Pacific bioinformatics market is categorized into six segments: by type, sector, application, purchase mode, genomics, and end user.
On the basis of by type, the Asia-Pacific bioinformatics market is segmented into Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform) Biological data interpretation, specialized bioinformatics application (single-cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression, and others), Services)
On the basis of by sector, the Asia-Pacific bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.
On the basis of application, Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics, and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services).
On the basis of purchase mode, the Asia-Pacific bioinformatics market is segmented into group purchases and individual purchases.
On the basis of genomics, the Asia-Pacific bioinformatics market is segmented into Genomics (DNA and RNA) and Proteomics.
On the basis of end-user, the Asia-Pacific bioinformatics market is segmented into Research and academic institute, Clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.
Market Players:
The key market players operating in the Asia-Pacific bioinformatics market are listed below:
Thermo Fisher Scientific
Illumina, Inc
Agilent Technologies, Inc
QIAGEN
SOPHiA GENETICS
BGI
Bayer AG
DNANEXUS, INC
PerkinElmer Inc.
Seven Bridges Genomics
Quest Diagnostics Incorporated
AstridBio Technologies Inc
BioBam
Strand Life Sciences
GenoFAB, Inc
TABLE OF CONTENTS
1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.3 OVERVIEW OF THE ASIA PACIFIC BIOINFORMATICS MARKET 32
1.4 CURRENCY AND PRICING 35
1.5 LIMITATION 35
1.6 MARKETS COVERED 35
2 MARKET SEGMENTATION 39
2.1 MARKETS COVERED 39
2.2 GEOGRAPHIC SCOPE 40
2.3 YEARS CONSIDERED FOR THE STUDY 41
2.4 CURRENCY AND PRICING 41
2.5 RESEARCH METHODOLOGY 42
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
2.7 MULTIVARIATE MODELLING 46
2.8 TYPE SEGMENT LIFELINE CURVE 46
2.9 DBMR MARKET POSITION GRID 47
2.10 VENDOR SHARE ANALYSIS 49
2.11 MARKET APPLICATION COVERAGE GRID 50
2.12 THE CATEGORY VS TIME GRID 51
2.13 SECONDARY SOURCES 52
2.14 ASSUMPTIONS 52
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 57
4.1 PESTEL 59
4.2 PORTER'S FIVE FORCES MODEL 60
5 REGULATIONS OF THE ASIA PACIFIC BIOINFORMATICS MARKET 61
6 MARKET OVERVIEW 64
6.1 DRIVERS 66
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE 66
6.1.2 GROWING NEED FOR BIOINFORMATICS 67
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS 68
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE 69
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 69
6.2 RESTRAINTS 70
6.2.1 HIGH COST OF INSTRUMENTATION 70
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS 70
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS 71
6.3 OPPORTUNITIES 71
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 71
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS 72
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 72
6.4 CHALLENGES 73
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY 73
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS 73
7 ASIA PACIFIC BIOINFORMATICS MARKET, BY TYPE 75
7.1 OVERVIEW 76
7.2 SERVICES 79
7.2.1 DIAGNOSTICS CONSULTATION 80
7.2.2 DATA ANALYSIS 80
7.2.2.1 STRUCTURAL 80
7.2.2.2 FUNCTIONAL 80
7.3 BIOINFORMATICS SOFTWARE 80
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP 82
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT 82
7.3.3 SEQUENCING DATA ANALYSIS 82
7.3.3.1 SEQUENCE ANALYSIS PLATFORM 83
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM 83
7.3.3.3 SEQUENCE MANIPULATION PLATFORM 83
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM 83
7.3.3.5 OTHERS 83
7.3.4 BIOLOGICAL DATA INTERPRETATION 83
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS 84
7.3.5.1 SINGLE CELL GENE EXPRESSION 84
7.3.5.2 GENE EXPRESSION 84
7.3.5.3 VARIANT DETECTION 84
7.3.5.4 CNV ANALYSIS 84
7.3.5.5 METAGENOMICS 85
7.3.5.6 METHYLATION 85
7.3.5.7 CHIP-SEQ 85
7.3.5.8 NON-CODING RNA EXPRESSION 85
7.3.5.9 OTHERS 85
7.3.6 OTHERS 85
7.4 KNOWLEDGE MANAGEMENT TOOLS 85
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 86
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 86
8 ASIA PACIFIC BIOINFORMATICS MARKET, BY SECTOR 87
8.1 OVERVIEW 88
8.2 MEDICAL BIOTECHNOLOGY 91
8.3 ACADEMICS 92
8.4 ANIMAL BIOTECHNOLOGY 93
8.5 AGRICULTURAL BIOTECHNOLOGY 93
8.6 ENVIRONMENTAL BIOTECHNOLOGY 94
8.7 FORENSIC BIOTECHNOLOGY 95
8.8 OTHERS 96
9 ASIA PACIFIC BIOINFORMATICS MARKET, BY APPLICATION 97
9.1 OVERVIEW 98
9.2 GENOMICS & DRUG DEVELOPMENT 101
9.2.1 SERVICES 102
9.2.2 SEQUENCING PLATFORMS 102
9.2.3 KNOWLEDGE MANAGEMENT TOOLS 102
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE 103
9.2.4.1 PREVENTIVE MEDICINE 103
9.2.4.2 MOLECULAR MEDICINE 103
9.2.4.3 PERSONALIZED MEDICINE 103
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN 103
9.2.4.5 ANTIBIOTIC RESISTANCE 103
9.3 PROTEOMICS 103
9.3.1 SERVICES 105
9.3.2 SERVICES SEQUENCING PLATFORMS 105
9.3.3 KNOWLEDGE MANAGEMENT TOOLS 105
9.4 AGRICULTURAL STUDIES 105
9.4.1 SERVICES 107
9.4.2 SERVICES SEQUENCING PLATFORMS 107
9.4.3 KNOWLEDGE MANAGEMENT TOOLS 107
9.5 TRANSCRIPTOMICS 107
9.5.1 SERVICES 108
9.5.2 SERVICES SEQUENCING PLATFORMS 108
9.5.3 KNOWLEDGE MANAGEMENT TOOLS 108
9.6 METABOLOMICS 108
9.6.1 SERVICES 110
9.6.2 SERVICES SEQUENCING PLATFORMS 110
9.6.3 KNOWLEDGE MANAGEMENT TOOLS 110
9.7 EVOLUTIONARY STUDIES 110
9.7.1 SERVICES 111
9.7.2 SERVICES SEQUENCING PLATFORMS 111
9.7.3 KNOWLEDGE MANAGEMENT TOOLS 111
9.8 VETERINARY SCIENCE 111
9.8.1 SERVICES 113
9.8.2 SERVICES SEQUENCING PLATFORMS 113
9.8.3 KNOWLEDGE MANAGEMENT TOOLS 113
9.9 OTHERS 113
9.9.1 SERVICES 115
9.9.2 SERVICES SEQUENCING PLATFORMS 115
9.9.3 KNOWLEDGE MANAGEMENT TOOLS 115
10 ASIA PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE 116
10.1 OVERVIEW 117
10.2 GROUP PURCHASE 120
10.3 INDIVIDUAL PURCHASE 120
11 ASIA PACIFIC BIOINFORMATICS MARKET, BY METHOD 122
11.1 OVERVIEW 123
11.2 GENOMICS 126
11.2.1 DNA 127
11.2.2 RNA 127
11.3 PROTEOMICS 127
12 ASIA PACIFIC BIOINFORMATICS MARKET, BY END USER 129
12.1 OVERVIEW 130
12.2 RESEARCH AND ACADEMIC INSTITUTES 133
12.3 CLINICAL RESEARCH ORGANIZATION 133
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES 134
12.5 RESEARCH LABORATORIES 135
12.6 HOSPITALS 136
12.7 OTHERS 137
13 ASIA PACIFIC BIOINFORMATICS MARKET, BY REGION 138
13.1 ASIA-PACIFIC 139
13.1.1 CHINA 149
13.1.2 JAPAN 155
13.1.3 INDIA 161
13.1.4 SOUTH KOREA 167
13.1.5 AUSTRALIA 173
13.1.6 SINGAPORE 179
13.1.7 THAILAND 185
13.1.8 MALAYSIA 191
13.1.9 INDONESIA 197
13.1.10 PHILIPPINES 203
13.1.11 REST OF ASIA-PACIFIC 209
14 ASIA PACIFIC BIOINFORMATICS MARKET: COMPANY LANDSCAPE 210
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 210
15 SWOT ANALYSIS 211
16 COMPANY PROFILE 212
16.1 BAYER AG 212
16.1.1 COMPANY SNAPSHOT 212
16.1.2 REVENUE ANALYSIS 212
16.1.3 COMPANY SHARE ANALYSIS 213
16.1.4 PRODUCT PORTFOLIO 213
16.1.5 RECENT DEVELOPMENTS 213
16.2 THERMO FISHER SCIENTIFIC INC 214
16.2.1 COMPANY SNAPSHOT 214
16.2.2 REVENUE ANALYSIS 214
16.2.3 COMPANY SHARE ANALYSIS 215
16.2.4 PRODUCT PORTFOLIO 215
16.2.5 RECENT DEVELOPMENTS 215
16.3 EUROFINS SCIENTIFIC 216
16.3.1 COMPANY SNAPSHOT 216
16.3.2 REVENUE ANALYSIS 216
16.3.3 COMPANY SHARE ANALYSIS 217
16.3.4 PRODUCT PORTFOLIO 217
16.3.5 RECENT DEVELOPMENTS 217
16.4 DASSAULT SYSTMES 218
16.4.1 COMPANY SNAPSHOT 218
16.4.2 REVENUE ANALYSIS 218
16.4.3 COMPANY SHARE ANALYSIS 219
16.4.4 PRODUCT PORTFOLIO 219
16.4.5 RECENT DEVELOPMENTS 219
16.5 AGILENT TECHNOLOGIES, INC 220
16.5.1 COMPANY SNAPSHOT 220
16.5.2 REVENUE ANALYSIS 220
16.5.3 COMPANY SHARE ANALYSIS 221
16.5.4 PRODUCT PORTFOLIO 221
16.5.5 RECENT DEVELOPMENTS 222
16.6 ASTRIDBIO TECHNOLOGIES INC. 223
16.6.1 COMPANY SNAPSHOT 223
16.6.2 PRODUCT PORTFOLIO 223
16.6.3 RECENT DEVELOPMENTS 223
16.7 BGI (A SUBSIDIARY OF BGI GROUP) 224
16.7.1 COMPANY SNAPSHOT 224
16.7.2 PRODUCT PORTFOLIO 224
16.7.3 RECENT DEVELOPMENTS 225
16.8 BIOBAM 226
16.8.1 COMPANY SNAPSHOT 226
16.8.2 PRODUCT PORTFOLIO 226
16.8.3 RECENT DEVELOPMENTS 226
16.9 DNANEXUS INC. 228
16.9.1 COMPANY SNAPSHOT 228
16.9.2 PRODUCT PORTFOLIO 228
16.9.3 RECENT DEVELOPMENTS 228
16.10 DNASTAR 229
16.10.1 COMPANY SNAPSHOT 229
16.10.2 PRODUCT PORTFOLIO 229
16.10.3 RECENT DEVELOPMENTS 229
16.11 GENOFAB, INC 230
16.11.1 COMPANY SNAPSHOT 230
16.11.2 PRODUCT PORTFOLIO 230
16.11.3 RECENT DEVELOPMENTS 230
16.12 ILLUMINA, INC 231
16.12.1 COMPANY SNAPSHOT 231
16.12.2 REVENUE ANALYSIS 231
16.12.3 PRODUCT PORTFOLIO 232
16.12.4 RECENT DEVELOPMENTS 232
16.13 PARTEK INCORPORATED 233
16.13.1 COMPANY SNAPSHOT 233
16.13.2 PRODUCT PORTFOLIO 233
16.13.3 RECENT DEVELOPMENTS 233
16.14 PERKINELMER INC. 234
16.14.1 COMPANY SNAPSHOT 234
16.14.2 PRODUCT PORTFOLIO 234
16.14.3 RECENT DEVELOPMENTS 235
16.15 QIAGEN 236
16.15.1 COMPANY SNAPSHOT 236
16.15.2 REVENUE ANALYSIS 236
16.15.3 PRODUCT PORTFOLIO 236
16.15.4 RECENT DEVELOPMENTS 237
16.16 QUEST DIAGNOSTICS INCORPORATED (2021) 238
16.16.1 COMPANY SNAPSHOT 238
16.16.2 REVENUE ANALYSIS 238
16.16.3 PRODUCT PORTFOLIO 239
16.16.4 RECENT DEVELOPMENTS 239
16.17 SEVEN BRIDGES GENOMICS 240
16.17.1 COMPANY SNAPSHOT 240
16.17.2 PRODUCT PORTFOLIO 240
16.17.3 RECENT DEVELOPMENTS 240
16.18 SOPHIA GENETICS 241
16.18.1 COMPANY SNAPSHOT 241
16.18.2 REVENUE ANALYSIS 241
16.18.3 PRODUCT PORTFOLIO 242
16.18.4 RECENT DEVELOPMENTS 242
16.19 STRAND LIFE SCIENCES 243
16.19.1 COMPANY SNAPSHOT 243
16.19.2 PRODUCT PORTFOLIO 243
16.19.3 RECENT VELOPMENTS 244
16.20 WATERS CORPORATION 245
16.20.1 COMPANY SNAPSHOT 245
16.20.2 PRODUCT PORTFOLIO 245
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
